| Literature DB >> 17479882 |
Lukas Fenner1, Rainer Weber, Robert Steffen, Patricia Schlagenhauf.
Abstract
We evaluated the epidemiologic factors of patients seeking treatment for travel-associated illness from January 2004 through May 2005 at the University Hospital of Zurich. When comparing persons whose purpose of travel was visiting friends and relatives (VFR travelers; n = 121) with tourists and other travelers (n = 217), VFR travelers showed a distinct infectious disease and risk spectrum. VFR travelers were more likely to receive a diagnosis of malaria (adjusted odds ratio [OR] = 2.9, 95% confidence interval [CI] 1.2-7.3) or viral hepatitis (OR = 3.1, 95% CI 1.1-9) compared with other travelers but were less likely to seek pretravel advice (20% vs. 67%, p = 0.0001). However, proportionate rates of acute diarrhea were lower in VFR (173 vs. 364 per 1,000 ill returnees). Travel to sub-Saharan Africa contributed most to malaria in VFR travelers. In countries with large migrant populations, improved public health strategies are needed to reach VFR travelers.Entities:
Mesh:
Year: 2007 PMID: 17479882 PMCID: PMC2725840 DOI: 10.3201/eid1302.060847
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
Demographics data on persons included in the study whose purpose of travel was visiting friends and relatives (VFR) versus traditional travelers (travelers)
| Travelers, no. (%) n = 217 | VFR, no. (%) n = 121 | p value | |
|---|---|---|---|
| Sex |
|
|
|
| Male | 119 (54.8) | 61 (50.4) | 0.43 |
| Female | 98 (45.2) | 60 (49.6) |
|
| Age (y) |
|
|
|
| Median | 32 | 39 | 0.008 |
| Interquartile range | 32–46 | 26–45 |
|
| Patient type |
|
|
|
| Outpatient | 185 (84.5) | 84 (70.6) | 0.002 |
| Inpatient | 34 (15.5) | 35 (29.4) |
|
| Travel duration (d) |
|
|
|
| Median | 15 | 21 | 0.006 |
| Interquartile range | 11–24 | 14–31 |
|
| Sought pretravel advice? |
|
|
|
| Yes | 65 (67) | 18 (20) | 0.0001 |
| No | 32 (33) | 70 (80) |
|
| Traveled region |
|
|
|
| Sub-Saharan Africa | 43 (19.81) | 27 (22.31) |
|
| Asia | 61 (28.11) | 21 (17.35) |
|
| Eastern Europe | 6 (2.76) | 21 (17.35) |
|
| Central/South America | 22 (10.13) | 9 (7.43) |
|
| All other regions | 85 (39.17) | 43 (35.53) |
Primary symptoms of persons seeking treatment at a clinic, frequent summary diagnosis, and syndrome groups in persons whose purpose of travel was visiting friends and relatives (VFR) versus traditional travelers (travelers)
| Travelers, no. (%)* | VFR, no. (%)* | |
|---|---|---|
| Primary symptom | ||
| Fever | 108 (49.76) | 57 (47.10) |
| Gastrointestinal | 117 (53.91) | 48 (39.66) |
| Head-ear-nose | 54 (24.88) | 38 (31.40) |
| Respiratory | 52 (23.96) | 34 (28.09) |
| Musculoskeletal | 25 (11.52) | 22 (18.18) |
| Skin | 30 (13.82) | 14 (11.57) |
| Fatigue | 24 (11.05) | 13 (10.74) |
| Other | 18 (8.29) | 16 (13.22) |
| Total | 428 | 242 |
| Summary diagnosis and syndrome groups | ||
| Diarrhea, acute | 79 (26.33) | 21 (11.53) |
| Respiratory infection | 40 (13.33) | 22 (12.09) |
| HIV/AIDS | 12 (4) | 15 (8.24) |
| Malaria, all species | 8 (2.67) | 14 (7.69) |
| Viral syndrome | 23 (7.67) | 10 (5.49) |
| Viral hepatitis, acute/chronic | 6 (2) | 10 (5.49) |
| Urinary tract infection | 3 (1) | 3 (1.65) |
| Febrile illness, unspecified | 10 (3.33) | 1 (0.55) |
| Dengue fever (uncomplicated) | 4 (1.33) | 1 (0.55) |
| Sexually transmitted infection | 1 (0.33) | 3 (1.65) |
| Loa loa | – | 2 (1.1) |
| Cutaneous leishmaniasis | 1 (0.33) | – |
| Typhoid/paratyphoid fever | 1 (0.33) | 1 (0.55) |
| Brucellosis | – | 1 (0.55) |
| Extraintestinal amebiasis | 1 (0.33) | –- |
| Dermatologic disorder | 22 (7.33) | 9 (4.95) |
| Chronic diarrhea | 7 (2.33) | 5 (2.75) |
| Healthy | 4 (1.33) | 2 (1.1) |
| Adverse drug or vaccine reaction | 3 (1) | 1 (0.55) |
| Cardiovascular disorder | 2 (0.67) | 3 (1.65) |
| Neurologic disorder | 2 (0.67) | 2 (1.1) |
| Lost to follow-up | 2 (0.67) | – |
| Pulmonary embolism | 1 (0.33) | 2 (1.1) |
| Psychological disorder | 1 (0.33) | 2 (1.1) |
| Death | 1 (0.33) | 1 (0.55) |
| Other diagnosis | 66 (22) | 51 (28.02) |
| Total | 300 | 182 |
*Percentage expressed as number of primary symptoms that led to a clinic visit per total patients in each group.
Association of infectious disease in persons whose purpose of travel was visiting friends and relatives (VFR) versus traditional travelers (travelers)*.
| Odds ratio | p value | 95% CI | |
|---|---|---|---|
| Univariate analysis | |||
| HIV/AIDS/STI | 2.42 | 0.019 | 1.15–5.07 |
| Malaria | 3.04 | 0.014 | 1.25–7.40 |
| Diarrhea, acute | 0.36 | 0.0001 | 0.21–0.61 |
| Viral hepatitis | 2.84 | 0.046 | 1.01–7.97 |
| Respiratory infection | 0.89 | 0.692 | 0.51–1.55 |
| Viral syndrome | 0.7 | 0.362 | 0.32–1.50 |
| Multivariate analysis (adjusted to age and sex) |
| ||
| HIV/AIDS/STI | 2.63 | 0.014 | 1.21–5.69 |
| Malaria | 2.93 | 0.021 | 1.17–7.32 |
| Diarrhea, acute | 0.47 | 0.007 | 0.27–0.81 |
| Viral hepatitis | 3.15 | 0.032 | 1.10–9.02 |
*CI, confidence interval; STI, sexually transmitted infection.
FigurePercentage of disease diagnoses in travelers visiting friends and relatives (VFR) and traditional travelers (trav) who reported illnesses after returning to Switzerland, classified by geographic region visited.